Stay updated on Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed. This is a versioning update related to study documents and does not change the study content.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0. This update does not modify the study details or user-facing content.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page adds a glossary toggle (Show glossary / Hide glossary) to help interpret terms, and includes minor editorial updates such as capitalization changes and a new Revision: v3.4.0 label.SummaryDifference0.3%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check62 days agoChange DetectedLocations sections were added and populated with study sites across Alabama, California, Florida, Indiana, Kentucky, Massachusetts, New Hampshire, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Texas, and Virginia. The page revision was updated to v3.3.3.SummaryDifference1%

- Check91 days agoChange DetectedPage footer revision updated from v3.2.0 to v3.3.2; no study content, eligibility criteria, or locations were changed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page.